Digital Pathology

The Digital Pathology panel can be used for many forms of CAR-T therapies & targets.Our team offers a broadly applicable, highly differentiated CAR-T assay that supports monitoring, distribution, and safety of CAR-T therapies in disease and normal tissue. Our team offers differentiated digital pathology assays to support in-depth understanding of tumor, immune and CAR-T cell biology in human FFPE tissues.













Our Digital Pathology applications includes:

  • Multiplex detection of target expression 
  • Clinical trial and diagnostic support 
  • Broad portfolio of immuno-oncology biomarkers

Validated Assay – Production Ready

  • Sensitivity
  • Specificity
  • Precision
  • Concordance
  • No Primary Antibody Control
  • Cut Section Stability

Automated Quantitative Analysis (AQUA) of Biomarkers in Tumor

Our AQUA platform provides the quantitation of biomarkers per unit area based on pixels produced by fluorescent antibodies. This pathologist developed-solution was specifically designeds to overcome subjective interpretation by the human eye.

Key benefits include:

  • Standardized for clinical applications & supported by >100 publications
  • Built under design control to enable companion diagnostics
  • Exclusive ownership of patents and product offerings by Navigate

Our quality and quest for excellence guide us in delivering multiplexing insights that are unmatched in the industry.